Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (439)	3/18/2003 9:53:33 AM
From: scaram(o)uche	Read Replies (1) of 598

>> They know how to spend... $475.1 million << That money has been used to establish an infrastructure. That infrastructure is, IMO, competent, top to bottom. It has stuck T67, T607, T487 and T131 into clinicals and established a pipeline which includes two anti-cancer drug candidates, one drug candidate for the treatment of immune disorders one anti-diabetic drug candidate in clinical testing, pre-clinical drug candidates in all six programs, and at least 25 drug leads. As you know, a good infrastructure can produce a "blockbuster", and a "blockbuster" can sell 10X that spend in a single year. A veteran biotech investor is not afraid of burn. He or she just labors to find good burn. Fingers crossed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next